InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by MOEBIUS HANS, Directeur Médical. Insider active across 1 companies, notably Athira Pharma, Inc.. Cumulatively, 6 filings have been published. Total volume traded: €27k. The latest transaction was disclosed on 28 June 2022 — Acquisition. Regulator: SEC (Form 4). All data is openly available.
Declarations6 total
€27,36710,000 shares@ €2.736725.9% of flow
Common Stock
SEC:0001209191-22-039937:0·
Ideal exit: 25 Mar 2023 (T+270)
€11,4531,699 shares@ €6.741310.8% of flow
Common Stock
SEC:0001209191-22-039343:0·
€9,161829 shares@ €11.050127.4% of flow
Common Stock
SEC:0001209191-22-004120·
€9,161829 shares@ €11.05018.7% of flow
Common Stock
SEC:0001209191-22-004120:0·
€24,2922,055 shares@ €11.82172.6% of flow
Common Stock
SEC:0001209191-21-047601·
€24,2922,055 shares@ €11.82123.0% of flow
Common Stock
SEC:0001209191-21-047601:0·
6 of 6 declarations
About MOEBIUS HANS
MOEBIUS HANS is Chief Medical Officer at Athira Pharma, Inc. In this role, he is responsible for medical strategy and overseeing clinical activities. His expertise in medicine and clinical research enables him to contribute to innovation and treatment improvement. Hans is committed to supporting Athira Pharma's mission of enhancing patients' lives.
